|
End-of-day quote
NSE India S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 1,875.00 INR | -0.01% |
|
+6.14% | +37.41% |
Company Valuation: Emcure Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Cap 1 | 203,202 | 302,490 | 355,650 | - | - |
| Change | - | 48.86% | 17.57% | - | - |
| Enterprise Value (EV) 1 | 208,106 | 306,160 | 362,034 | 352,372 | 340,152 |
| Change | - | 47.12% | 18.25% | -2.67% | -3.47% |
| P/E | 29.4x | 32.7x | 29.9x | 24.1x | 20.2x |
| PBR | 4.57x | - | 5.84x | 4.75x | 3.9x |
| PEG | - | 1x | 1x | 1x | 1x |
| Capitalization / Revenue | 2.57x | 3.29x | 3.35x | 2.97x | 2.65x |
| EV / Revenue | 2.64x | 3.33x | 3.41x | 2.94x | 2.54x |
| EV / EBITDA | 14.2x | 17.1x | 16.7x | 13.9x | 11.7x |
| EV / EBIT | 19.2x | 22.3x | 21.3x | 17.1x | 14.1x |
| EV / FCF | 33x | 52.5x | 36.6x | 29.8x | 22.8x |
| FCF Yield | 3.03% | 1.9% | 2.73% | 3.36% | 4.38% |
| Dividend per Share 2 | 3 | 3.6 | 4.007 | 4.728 | 5.773 |
| Rate of return | 0.28% | 0.23% | 0.21% | 0.25% | 0.31% |
| EPS 2 | 36.43 | 48.77 | 62.72 | 77.66 | 92.93 |
| Distribution rate | 8.23% | 7.38% | 6.39% | 6.09% | 6.21% |
| Net sales 1 | 78,960 | 92,035 | 106,051 | 119,824 | 133,996 |
| EBITDA 1 | 14,689 | 17,890 | 21,618 | 25,428 | 29,101 |
| EBIT 1 | 10,847 | 13,740 | 17,017 | 20,571 | 24,113 |
| Net income 1 | 6,813 | 9,244 | 11,895 | 14,608 | 17,577 |
| Net Debt 1 | 4,904 | 3,670 | 6,384 | -3,278 | -15,498 |
| Reference price 2 | 1,072.40 | 1,595.50 | 1,875.00 | 1,875.00 | 1,875.00 |
| Nbr of stocks (in thousands) | 189,483 | 189,590 | 189,680 | - | - |
| Announcement Date | 5/22/25 A | 5/5/26 A | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.9x | 3.41x | 16.75x | 0.21% | 3.74B | ||
| 37.66x | 13.18x | 27.98x | 0.53% | 1,143B | ||
| 39.33x | 6.61x | 18.6x | 1.99% | 647B | ||
| 37.45x | 8.4x | 17.37x | 2.4% | 506B | ||
| 21.46x | 5.22x | 12.98x | 2.51% | 384B | ||
| 103.38x | 5.8x | 24.86x | 2.4% | 350B | ||
| 21.99x | 5.69x | 13.69x | 2.94% | 293B | ||
| 22.31x | 4.51x | 12.87x | 1.96% | 265B | ||
| 28.42x | 7.28x | 13.03x | 2.25% | 242B | ||
| -45.78x | 7.1x | 27.53x | 2.07% | 197B | ||
| Average | 29.61x | 6.72x | 18.57x | 1.93% | 403.13B | |
| Weighted average by Cap. | 35.27x | 8.35x | 20.48x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EMCURE Stock
- Valuation Emcure Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















